Your browser doesn't support javascript.
loading
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial.
Wu, Xilin; Senanayake, Russell; Goodchild, Emily; Bashari, Waiel A; Salsbury, Jackie; Cabrera, Claudia P; Argentesi, Giulia; O'Toole, Samuel M; Matson, Matthew; Koo, Brendan; Parvanta, Laila; Hilliard, Nick; Kosmoliaptsis, Vasilis; Marker, Alison; Berney, Daniel M; Tan, Wilson; Foo, Roger; Mein, Charles A; Wozniak, Eva; Savage, Emmanuel; Sahdev, Anju; Bird, Nicholas; Laycock, Kate; Boros, Istvan; Hader, Stefan; Warnes, Victoria; Gillett, Daniel; Dawnay, Anne; Adeyeye, Elizabeth; Prete, Alessandro; Taylor, Angela E; Arlt, Wiebke; Bhuva, Anish N; Aigbirhio, Franklin; Manisty, Charlotte; McIntosh, Alasdair; McConnachie, Alexander; Cruickshank, J Kennedy; Cheow, Heok; Gurnell, Mark; Drake, William M; Brown, Morris J.
Afiliación
  • Wu X; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Senanayake R; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Goodchild E; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Bashari WA; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Salsbury J; NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Cabrera CP; Department of Diabetes and Endocrinology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Argentesi G; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • O'Toole SM; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Matson M; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Koo B; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
  • Parvanta L; NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Hilliard N; Department of Diabetes and Endocrinology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Kosmoliaptsis V; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Marker A; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Berney DM; Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Tan W; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Foo R; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Mein CA; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Wozniak E; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Savage E; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Sahdev A; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Bird N; Department of Endocrinology, Royal Hallamshire Hospital, Sheffield, United Kingdom.
  • Laycock K; Department of Radiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Boros I; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Hader S; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Warnes V; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Gillett D; Department of Surgery, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Dawnay A; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Adeyeye E; Department of Histopathology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Prete A; Cardiovascular Research Institute, National University of Singapore, Singapore, Singapore.
  • Taylor AE; Cardiovascular Research Institute, National University of Singapore, Singapore, Singapore.
  • Arlt W; Barts and the London Genome Centre, School of Medicine and Dentistry, Blizard Institute, London, United Kingdom.
  • Bhuva AN; Barts and the London Genome Centre, School of Medicine and Dentistry, Blizard Institute, London, United Kingdom.
  • Aigbirhio F; Barts and the London Genome Centre, School of Medicine and Dentistry, Blizard Institute, London, United Kingdom.
  • Manisty C; Department of Radiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • McIntosh A; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • McConnachie A; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Cruickshank JK; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Cheow H; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Gurnell M; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom.
  • Drake WM; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom.
  • Brown MJ; Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Nat Med ; 29(1): 190-202, 2023 01.
Article en En | MEDLINE | ID: mdl-36646800
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tomografía Computarizada por Tomografía de Emisión de Positrones / Hiperaldosteronismo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tomografía Computarizada por Tomografía de Emisión de Positrones / Hiperaldosteronismo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article